Guardant Health, Inc. (GH)
Healthcare · Services-Medical Laboratories
Guardant Health, Inc. (GH) stock research on InvestAtlant: institutional ownership from 13F filings, insider Form 4 activity, and SEC context.
Top institutional holders (2026-Q3)
| Institution | Shares | Value | % Outstanding |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 2,544,956 | $454.03M | 1.89% |
| AGF MANAGEMENT LTD | 1,131,513 | $201.82M | 0.84% |
| Bank of New York Mellon Corp | 1,076,285 | 74.13M | 0.80% |
| Temasek Holdings (Private) Ltd | 1,057,711 | 88.65M | 0.79% |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 937,974 | 67.30M | 0.70% |
| Allspring Global Investments Holdings, LLC | 730,980 | 27.74M | 0.54% |
| DIMENSIONAL FUND ADVISORS LP | 440,424 | $78.55M | 0.33% |
| Sumitomo Mitsui Trust Group, Inc. | 324,732 | $57.92M | 0.24% |
Recent insider transactions
| Date | Insider | Title | Type | Value |
|---|---|---|---|---|
| 2026-10-16 | Tariq Musa | Director | Sale | 9.2K |
| 2026-10-14 | Azar Alex M II | Director | Sale | 1.0K |
| 2026-09-16 | Tariq Musa | Director | Sale | $20.3K |
| 2026-09-16 | Krognes Steve E. | Director | Sale | $578.9K |
| 2026-09-16 | Krognes Steve E. | Director | Sale | 72.3K |
| 2026-09-16 | Krognes Steve E. | Director | Sale | 92.4K |
| 2026-09-16 | Krognes Steve E. | Director | Sale | $229.2K |
| 2026-09-16 | Azar Alex M II | Director | Sale | 44.6K |